| 87 |
X |
X |
|
2021 |
Acute Med Surg 8(1):e648(2021) |
Influence of high‐dose antithrombin on platelet function and blood coagulation
|
T Miike
|
| 75 |
X |
|
|
2020 |
Blood Adv 4 (21): 5501-5511(2020) |
Activated platelet-based inhibition of fibrinolysis via thrombin-activatable fibrinolysis inhibitor activation system
|
Y Suzuki
|
| 73 |
X |
|
|
2020 |
Int J Cardiol S0167-5273(20),p33924-33933(2020) |
Development and assessment of total thrombus-formation analysis system-based bleeding risk model in patients undergoing percutaneous coronary intervention
|
N Nakanishi
|
| 72 |
X |
X |
|
2020 |
Pol Arch Intern Med 130(12),p1114-1117(2020) |
Can Total Thrombus-formation Analysis System (T-TAS®) better predict coagulation disturbances than conventional laboratory measurements in patients with polycystic ovary syndrome?
|
K Ożegowska
|
| 70 |
X |
|
|
2020 |
PLoS ONE 15(10): e0237843(2020) |
Poor glycaemic control contributes to a shift towards prothrombotic and antifibrinolytic state in pregnant women with type 1 diabetes mellitus
|
M Osiński
|
| 69 |
X |
X |
|
2020 |
Pediatr Int (2020) |
A microchip flow-chamber assay screens congenital primary hemostasis disorders
|
Y Nakajima
|
| 68 |
X |
|
|
2020 |
Thromb Res 194,p98-100(2020) |
Results of in vitro whole blood coagulation assays using ROTEM and the flow-chamber T-TAS system are affected by hematocrit
|
A Ågren
|
| 67 |
X |
X |
|
2020 |
Kardiol Pol 78(7-8),p667-673(2020) |
New methodological approaches for assessing thrombus formation in cardiovascular disease
|
K Hosokawa
|
| 64 |
X |
|
|
2020 |
Int J Mol Sci 21(11),3972(2020) |
E8002 Inhibits Peripheral Nerve Adhesion by Enhancing Fibrinolysis of l-Ascorbic Acid in a Rat Sciatic Nerve Model
|
K Kikuchi
|
| 62 |
X |
X |
|
2020 |
Front Vet Sci 7:307(2020) |
A Novel Microchip Flow Chamber (Total Thrombus Analysis System) to Assess Canine Hemostasis
|
T Iwanaga
|
| 61 |
X |
|
|
2020 |
In Vivo 34(4),p1871-1874(2020) |
Association Between HMGB1 and Thrombogenesis in a Hyperlipaemia-induced Microminipig Model of Atherosclerosis
|
S Kase
|
| 60 |
X |
X |
|
2020 |
Circ J 84(6),p975-984(2020) |
Platelet-Derived Thrombogenicity Measured by Total Thrombus-Formation Analysis System in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention
|
S Kikuchi
|
| 58 |
X |
X |
|
2019 |
Int J Hematol 111, p369-377(2020) |
Evaluation of clinical severity in patients with type 2N von Willebrand disease using microchip-based flow-chamber system
|
Y Nakajima
|
| 57 |
X |
X |
|
2019 |
J Atheroscler Thromb 27(3),p201-203(2020) |
Monitoring of Antithrombotic Therapy
|
M Yamazaki
|
| 56 |
X |
X |
|
2019 |
Thromb J 17, 17 (2019) |
Effects of glycemic control and hypoglycemia on Thrombus formation assessed using automated microchip flow chamber system: an exploratory observational study observational study
|
K Yamamoto
|
| 55 |
X |
X |
|
2019 |
J Atheroscler Thromb 27,p215-225(2020) |
Total Thrombus-Formation Analysis System can Predict 1-Year Bleeding Events in Patients with Coronary Artery Disease
|
T Mitsuse
|
| 54 |
X |
X |
|
2019 |
Thromb Haemost 119,p1554-1562(2019) |
Total Thrombus-Formation Analysis System (T-TAS): Clinical Application of Quantitative Analysis of Thrombus Formation in Cardiovascular Disease
|
K Kaikita
|
| 53 |
X |
X |
|
2019 |
Sci Rep 9:6573(2019) |
Sulfenamide and Sulfonamide Derivatives of Metformin – A New Option to Improve Endothelial Function and Plasma Haemostasis
|
MM Piasecka
|
| 52 |
X |
X |
|
2019 |
Circ J 83(6),p1309-1316(2019) |
Impact of Total Antithrombotic Effect on Bleeding Complications in Patients Receiving Multiple Antithrombotic Agents
|
S Ichikawa
|
| 51 |
X |
|
|
2019 |
Int J Cardiol Heart Vasc 23:100346(2019) |
Reduction in thrombogenic activity and thrombocytopenia after transcatheter aortic valve implantation – The ATTRACTIVE-TTAS study
|
M Ishii
|
